Inner ear perfusion: Indications and applications

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 11, Issue 5, 2003, Pages 334-339

  Hoffmann, Karen K ^a   Silverstein, Herbert ^a  

^a Ear Research Foundation   (United States)

Author keywords

Inner ear perfusion

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; STEROID;

AUTOIMMUNE DISEASE; AVASCULAR NECROSIS; CATHETERIZATION; DRUG DELIVERY SYSTEM; ENDOTHELIUM; HUMAN; INNER EAR; INNER EAR DISEASE; INSOMNIA; MENIERE DISEASE; MOOD DISORDER; MYRINGOTOMY; OTOTOXICITY; PERCEPTION DEAFNESS; PERFUSION; PRIORITY JOURNAL; REVIEW; STOMACH ULCER; SURGICAL TECHNIQUE; SYSTEMIC DISEASE; TYMPANOSTOMY TUBE; VASCULITIS; VERTIGO;

AUTOIMMUNE DISEASES; CATHETERS, INDWELLING; DRUG DELIVERY SYSTEMS; EAR DISEASES; EAR, INNER; HEARING LOSS, SUDDEN; HUMANS; MENIERE'S DISEASE; TYMPANIC MEMBRANE;

EID: 0141617516     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200310000-00005     Document Type: Review

References (38)

1. Schuknecht HF: Ablation therapy for relief of Meniere's disease. Laryngoscope 1956, 66:859-870.
2. Jackson LE, Silverstein H: Chemical perfusion of the inner ear. Otolaryngol Clin North Am 2002, 35:639-653.A thorough review of chemical perfusion of the inner ear. Describes the science behind the procedure and the surgical techniques, and summarizes the results of treatment.
3. Smith BM, Myers MG: The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg 1979, 87:888-891.
4. Youssef TF, Poe DS: Intratympanic gentamicin injection for the treatment of Meniere's disease. Am J Otol 1998, 19:435-442.
5. Salt AN, Ma Y: Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 2001, 154:88-97.
6. Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al.: Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000, 122:521-528.
7. Parnes LS, Sun AH, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999, 109:1-17.
8. Beck C, Schmidt CL: 10 Years experience with intratympanically applied streptomycin (gentamicin) in the therapy of Morbus Meniere. Arch Otorhinolaryngol 1978, 221:149-152.
9. Nedzelski JM, Bryce GE, Pfleiderer AG: Treatment of Meniere's disease with topical gentamicin: a preliminary report. J Otolaryngol 1992, 21:95-101.
10. Nedzelski JM, Schessel DA, Bryce GE, et al.: Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992, 13:18-22.
11. Silverstein H, Lewis WB, Jackson U, et al.: Changing trends in the surgical treatment of Meniere's disease: results of a 10-year study. Ear Nose Throat J 2003, 82:185-194.
12. Byl FM, Freeman MA, Haberkamp TJ, et al.: Sudden sensorineural hearing loss. Otolaryngol Clin North Am 1996, 29:393-405.
13. Byl FM Jr: Sudden hearing loss: eight years' experience & suggested prognostic table. Laryngoscope 1984, 94:647-661.
14. Mattox DE, Simmons FB: Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977, 86:463-480.
15. Kellerhals B, Hippert F, Pfaltz CR: Treatment of acute acoustic trauma with low molecular weight dextran. Pract Otorhinolaryngol 1971, 33:260-264.
16. Tange A: Vascular structures of the inner ear. In Inner Ear Partition. Edited by Ars B. The Hague, Netherlands: Kugler; 1997:5-11.
17. Poridda A, Saggese D, Ferri GG, et al.: The role of hypotension in the pathogenesis of sudden hearing loss. Audiology 1997, 36:98-108.
18. Gloddek B, Lamm K, Arnold W: Pharmacological influence on inner ear endothelial cells in relation to the pathogenesis if sensorineural hearing loss. In Rationls Pharmacotherapy of the Inner Ear. Adv Otorhinolaryngol Edited Felix D, Oestreicher E. Basel: S Karger AG; 2002, 59:75-83.
19. Haberkamp TJ, Tanyeri HM: Management of idiopathic sudden sensorineural hearing loss. Am J Otol 1999, 20:587-592.
20. Wilson WR, Byle F, Laird N: The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol 1980, 106:772-776.
21. Gloddek B, Gloddek J, Arnold W: Induction of autoimmune labyrinthitis by transfer of inner ear specific T-helper cells. Ann N Y Acad Sci 1997, 830:235-265.
22. Gloddek B, Lassmann S, Gloddek J, et al.: Role of the protein S-100 as potential autoantigen during an autoimmune disease of the inner ear. J Neuroimmunol 1999, 99:451-457.
23. Abbas AK, Lichtman AH, Pober JS: Immunologie. Bern, Switzerland: Huber; 1996:479-487.
24. Triolo G: Enhancement of endothelial cell E-selectin expression by sera from patients with active Behcet's disease: moderate correlation with antiendothelial cell antibodies and serum myeloperoxidase levels. Clin Immunol 1999, 91:330-337.
25. Hoffer ME, Balough B, Henderson J, et al.: Use of sustained release vehicles in the treatment of Meniere's disease. Otolaryngol Clin North Am 1997, 30:1159-1166.
26. DeCicco MJ, Hoffer ME, Kopke RD, et al.: Round-window microcatheter-administered microdose gentamicin: results from treatment of tinnitus associated with Meniere's disease. Int Tinnitus J 1998, 4:141-143.
27. Silverstein H, Durand B, Jackson LE, et al.: Use of the malleus handle as a landmark for localization of the round window membrane. Ear Nose Throat J 2001, 80:444-448.
28. Assimakopoulos D, Patrikakos G: Treatment of Meniere's disease by intratympanic gentamicin application. J Laryngol Otol 2003, 117:10-16. An excellent review of intratympanic gentamicin for the treatment of Meniere disease-from basic science to clinical application.
29. Perez N, Martin E, Garcia-Tapia R: Intratympanic gentamicin for intractable Meniere's disease. Laryngoscope 2003, 113:456-464.
30. Light JP, Silverstein H, Jackson LE; Gentamicin perfusion, vestibular response and hearing loss. Otol Neurotol 2003, 24:294-298. A good retrospective review of hearing results and degree of vestibular ablation in patients undergoing inner ear perfusion of gentamicin for intractable Meniere disease.
31. Kaplan DM, Nedzelski JM, Al-Abidi A, et al.: Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease. J Otolaryngol 2002, 31:106-111. A thorough retrospective analysis of the incidence, extent, and time course of hearing loss after intratympanic gentamicin using a fixed protocol.
32. Silverstein H, Light JP, Jackson LE, et al.: Dexamethasone inner ear perfusion for the treatment of sudden deafness. Presented at Amer Acad Otolaryngol Head Neck Surg Annual Meeting, San Diego, CA, September 2002.
33. Lefebvre PP, Staecker H: Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 2002, 122:698-702. A good preliminary study examining the role for steroid perfusion of the inner ear for severe, sudden hearing loss unresponsive to medical therapy, although the patient population was small.
34. Fisch U: Management of sudden deafness. Otolaryngol Head Neck Surg 1983, 91:3-8.
35. Yang GS, Song HT, Keithley EM, et al.: Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Am J Otol 2000, 21:499-504.
36. Plontke SKR, Wood AW, Salt AN: Analysis of gentamicin kinetics in fluids of the inner ear with round window administration. Otol Neurotol 2002, 23:967-974.
37. Weisskopf P, Hoffer ME, Kopke RD, et al.: Microdose gentamicin delivered via the round window microcatheter: a therapeutic option in Meniere's disease. Oper Tech Otolaryngol Head Neck Surg 2001, 12:154-156.
38. Silverstein H, Jackson LE, Rosenberg SI. Silverstein MicroWick for the treatment of inner ear disease. Oper Tech Otolaryngol Head Neck Surg 2001, 12:44-47.